160 related articles for article (PubMed ID: 8059925)
21. Prenatal diagnosis of rhizomelic chondrodysplasia punctata.
Hoefler S; Hoefler G; Moser AB; Watkins PA; Chen WW; Moser HW
Prenat Diagn; 1988 Oct; 8(8):571-6. PubMed ID: 3205862
[TBL] [Abstract][Full Text] [Related]
22. A prenatal test for the cerebro-hepato-renal (Zellweger) syndrome by demonstration of the absence of catalase-containing particles (peroxisomes) in cultured amniotic fluid cells.
Wanders RJ; Schrakamp G; van den Bosch H; Tager JM; Schutgens RB
Eur J Pediatr; 1986 Apr; 145(1-2):136-8. PubMed ID: 3732317
[TBL] [Abstract][Full Text] [Related]
23. Peroxisomal disorders in neurology.
Wanders RJ; Heymans HS; Schutgens RB; Barth PG; van den Bosch H; Tager JM
J Neurol Sci; 1988 Dec; 88(1-3):1-39. PubMed ID: 3066850
[TBL] [Abstract][Full Text] [Related]
24. Biochemical features of a patient with Zellweger-like syndrome with normal PTS-1 and PTS-2 peroxisomal protein import systems: a new peroxisomal disease.
Singh I; Voigt RG; Sheikh FG; Kremser K; Brown FR
Biochem Mol Med; 1997 Aug; 61(2):198-207. PubMed ID: 9259985
[TBL] [Abstract][Full Text] [Related]
25. Genetic diseases caused by peroxisomal dysfunction. New findings in clinical and biochemical studies.
Schutgens RB; Wanders RJ; Nijenhuis A; van den Hoek CM; Heymans HS; Schrakamp G; Bleeker-Wagemakers EM; Delleman JW; Schram AW; Tager JM
Enzyme; 1987; 38(1-4):161-76. PubMed ID: 3440444
[TBL] [Abstract][Full Text] [Related]
26. Molecular analysis of peroxisomal beta-oxidation enzymes in infants with peroxisomal disorders indicates heterogeneity of the primary defect.
Guerroui S; Aubourg P; Chen WW; Hashimoto T; Scotto J
Biochem Biophys Res Commun; 1989 May; 161(1):242-51. PubMed ID: 2471528
[TBL] [Abstract][Full Text] [Related]
27. New insights in peroxisomal beta-oxidation. Implications for human peroxisomal disorders.
Van Veldhoven PP
Verh K Acad Geneeskd Belg; 1998; 60(3):195-214. PubMed ID: 9803880
[TBL] [Abstract][Full Text] [Related]
28. Peroxisomal very long-chain fatty acid beta-oxidation in human skin fibroblasts: activity in Zellweger syndrome and other peroxisomal disorders.
Wanders RJ; van Roermund CW; van Wijland MJ; Heikoop J; Schutgens RB; Schram AW; Tager JM; van den Bosch H; Poll-Thé BT; Saudubray JM
Clin Chim Acta; 1987 Jul; 166(2-3):255-63. PubMed ID: 2441904
[TBL] [Abstract][Full Text] [Related]
29. Formation of a novel arachidonic acid metabolite in peroxisomes.
Gordon JA; Heller SK; Rhead WJ; Watkins PA; Spector AA
Prostaglandins Leukot Essent Fatty Acids; 1995; 52(2-3):77-81. PubMed ID: 7540307
[TBL] [Abstract][Full Text] [Related]
30. Peroxisomal 3-ketoacyl-CoA thiolase is partially processed in fibroblasts from patients with rhizomelic chondrodysplasia punctata.
Suzuki Y; Shimozawa N; Izai K; Uchida Y; Miura K; Akatsuka H; Nagaya M; Yamaguchi S; Orii T
J Inherit Metab Dis; 1993; 16(5):868-71. PubMed ID: 8295403
[No Abstract] [Full Text] [Related]
31. Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders.
Poll-The BT; Skjeldal OH; Stokke O; Poulos A; Demaugre F; Saudubray JM
Hum Genet; 1989 Jan; 81(2):175-81. PubMed ID: 2463966
[TBL] [Abstract][Full Text] [Related]
32. Identification of the peroxisomal beta-oxidation enzymes involved in the biosynthesis of docosahexaenoic acid.
Ferdinandusse S; Denis S; Mooijer PA; Zhang Z; Reddy JK; Spector AA; Wanders RJ
J Lipid Res; 2001 Dec; 42(12):1987-95. PubMed ID: 11734571
[TBL] [Abstract][Full Text] [Related]
33. Peroxisomes of normal morphology but deficient in 3-oxoacyl-CoA thiolase in rhizomelic chondrodysplasia punctata fibroblasts.
Heikoop JC; Van den Berg M; Strijland A; Weijers PJ; Schutgens RB; Just WW; Wanders RJ; Tager JM
Biochim Biophys Acta; 1991 Jul; 1097(1):62-70. PubMed ID: 1677591
[TBL] [Abstract][Full Text] [Related]
34. Peroxisomal beta-oxidation enzyme proteins in adrenoleukodystrophy: distinction between X-linked adrenoleukodystrophy and neonatal adrenoleukodystrophy.
Chen WW; Watkins PA; Osumi T; Hashimoto T; Moser HW
Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1425-8. PubMed ID: 3469675
[TBL] [Abstract][Full Text] [Related]
35. Peroxisomal beta-oxidation enzyme proteins in the Zellweger syndrome.
Tager JM; Van der Beek WA; Wanders RJ; Hashimoto T; Heymans HS; Van den Bosch H; Schutgens RB; Schram AW
Biochem Biophys Res Commun; 1985 Feb; 126(3):1269-75. PubMed ID: 3977916
[TBL] [Abstract][Full Text] [Related]
36. Peroxisome mosaicism in the livers of peroxisomal deficiency patients.
Espeel M; Mandel H; Poggi F; Smeitink JA; Wanders RJ; Kerckaert I; Schutgens RB; Saudubray JM; Poll-The BT; Roels F
Hepatology; 1995 Aug; 22(2):497-504. PubMed ID: 7635418
[TBL] [Abstract][Full Text] [Related]
37. Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analysis.
Verhoeven NM; Jakobs C; ten Brink HJ; Wanders RJ; Roe CR
J Inherit Metab Dis; 1998 Oct; 21(7):753-60. PubMed ID: 9819705
[TBL] [Abstract][Full Text] [Related]
38. Human peroxisomal 3-oxoacyl-coenzyme A thiolase deficiency.
Schram AW; Goldfischer S; van Roermund CW; Brouwer-Kelder EM; Collins J; Hashimoto T; Heymans HS; van den Bosch H; Schutgens RB; Tager JM
Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2494-6. PubMed ID: 2882519
[TBL] [Abstract][Full Text] [Related]
39. A new type of peroxisomal disorder with variable expression in liver and fibroblasts.
Mandel H; Espeel M; Roels F; Sofer N; Luder A; Iancu TC; Aizin A; Berant M; Wanders RJ; Schutgens RB
J Pediatr; 1994 Oct; 125(4):549-55. PubMed ID: 7931872
[TBL] [Abstract][Full Text] [Related]
40. Molecular analysis of peroxisomal beta-oxidation enzymes in infants with Zellweger syndrome and Zellweger-like syndrome: further heterogeneity of the peroxisomal disorder.
Suzuki Y; Shimozawa N; Orii T; Igarashi N; Kono N; Hashimoto T
Clin Chim Acta; 1988 Feb; 172(1):65-76. PubMed ID: 2452040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
